Hanbin Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hanbin Zhang has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Jian Guan
Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
26 shared publications - Bei Chen
Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China. 1
25 shared publications - Feng Ye
Department of Radiotherapy, Nanfang Hospital, Southern Medical University, Guangzhou, China
25 shared publications - Jianda Sun
Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China. 1
25 shared publications - Longshan Zhang
Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China. 1
25 shared publications - Min Chen
Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China. 1
25 shared publications
Latest Publications
- Open Access
- 15 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
Supplementary Figure S3. Confusion matrices and Metric for 4 models
- 15 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
Supplementary Figure S3. Confusion matrices and Metric for 4 models
- Open Access
- 15 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
Supplementary Figure S1. Diagram of Lipoprotein and the pre-possessing of metabolites profile
- 15 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
Supplementary Figure S1. Diagram of Lipoprotein and the pre-possessing of metabolites profile
- Open Access
- 15 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
Supplementary Table S1 List of all sub-classes of Lipoproteins in plasma
- 15 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
Supplementary Table S1 List of all sub-classes of Lipoproteins in plasma
- Open Access
- 15 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S7 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
Supplementary Table S7 Contributions of features in the XGB model
- 15 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S7 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
Supplementary Table S7 Contributions of features in the XGB model
- Open Access
- 15 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S7 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
Supplementary Table S7 Contributions of features in the XGB model
- 15 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S7 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
Supplementary Table S7 Contributions of features in the XGB model
- Open Access
- 15 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
Supplementary Table S2 List of lipoproteins measured by 1H-NMR
- 15 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
Supplementary Table S2 List of lipoproteins measured by 1H-NMR
- Open Access
- 15 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
Supplementary Figure S2. Comparison of different lipoprotein profiles between patients with different IC efficacy
- 15 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
Supplementary Figure S2. Comparison of different lipoprotein profiles between patients with different IC efficacy
- Open Access
- 15 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Materials S1 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
Supplementary Materials of raw data behind figures and tables in manuscript
- 15 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Materials S1 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
Supplementary Materials of raw data behind figures and tables in manuscript
- Open Access
- 15 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Materials S1 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
Supplementary Materials of raw data behind figures and tables in manuscript
- 15 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Materials S1 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
Supplementary Materials of raw data behind figures and tables in manuscript
- Open Access
- 15 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
Supplementary Table S6 Performance metrics for prediction models in the discovery cohort
- 15 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
Supplementary Table S6 Performance metrics for prediction models in the discovery cohort